Adam Feinberg leads the regenerative biomaterials and therapeutics group in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University. He earned his B.S. in engineering from Cornell University in 1999 with co-op experience at Abiomed, Inc., working on total artificial hearts. He then earned an M.S. and doctorate in biomedical engineering from the University of Florida, followed by postdoctoral training at Harvard University, developing new biomaterials and stem cell-based cardiac tissue engineering strategies. Adam has co-authored over 45 peer-reviewed publications, holds over 20 U.S. patents and patent applications and is co-founder and CTO of FluidForm LLC, a 3D bio-printing startup. He has been awarded the NSF CAREER award, the NIH Director’s New Innovator Award, and the American Heart Association Scientist Development Grant.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.